arrow
I

Ilesh Jani

Instituto Nacional de Saude
H指数:37
被引数:4,443

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Point-of-care early infant HIV diagnosis at birth in a pragmatic cluster-randomized trial in Mozambique and Tanzania: A comparative cost and cost-effectiveness study

在莫桑比克和坦桑尼亚进行的实用性集群随机试验中,出生时进行早期婴儿HIV诊断的床旁检测:一项比较成本和成本效益的研究

2026-05-010
OA
The future of diagnostics in Africa

非洲诊断的未来

2026-04-220
PRE
Intramuscular versus intradermal administration of fractional dose inactivated poliovirus vaccine in Mozambique, 2020–2022: an, open-label, non-inferiority, randomised, controlled phase 2 trial

肌内注射与皮内注射分剂量灭活脊髓灰质炎病毒疫苗在莫桑比克,2020–2022年:一项开放标签、非劣效性、随机对照2期试验

2025-12-030
OAAI
Impact of point-of-care maternal viral load testing at delivery on vertical HIV transmission risk assessment and neonatal prophylaxis: a cluster randomized trial

产时床旁母体病毒载量检测对垂直HIV传播风险评估和新生儿预防的影响:一项群组随机试验

2025-07-280
OAAI
Real-world Evaluation of the Effectiveness of Sinopharm COVID-19 Vaccine Against Symptomatic COVID-19 in an Omicron-Dominant Setting in Mozambique: A Test-Negative, Case-Control Study

在奥密克戎主导环境下莫桑比克症状性COVID-19中科兴新冠疫苗有效性的真实世界评估:一项测试阴性、病例对照研究

2025-06-151
OAAI
Overcoming Vaccine Inequities and Research Gaps in Africa: Challenges and Opportunities Identified During the COVID-19 Pandemic

克服非洲的疫苗不平等和研究差距:COVID-19大流行期间识别的挑战与机遇

2025-06-153
PRE
Hybrid Immunity in a Mozambican Cohort After 1 or 2 Doses of the BBIBP-CorV Vaccine

莫桑比克队列中接种1剂或2剂BBIBP-CorV疫苗后的混合免疫

2025-06-150
OAAI
Immunogenicity and Safety of Heterologous Versus Homologous Prime-Boost Regimens With BBIBP-CorV and Ad26.COV2.S COVID-19 Vaccines: A Multicentric, Randomized, Observer-Blinded Non-inferiority Trial in Madagascar and Mozambique

异源与同源初始-加强免疫方案中使用BBIBP-CorV和Ad26.COV2.S COVID-19疫苗的免疫原性和安全性:一项在马达加斯加和莫桑比克开展的多中心、随机、观察者盲法非劣效性试验

2025-06-151
OAAI
Impact of Point-of-Care Birth Test-and-Treat on Clinical Outcomes Among Infants With Human Immunodeficiency Virus: A Cluster-Randomized Trial in Mozambique and Tanzania
2024-11-080
OAAI
HIV incidence and its associated factors among young adults with multiple sexual partners in Maputo, Mozambique: a vaccine preparedness study
2024-10-021
OAAI
Safety and Immunogenicity of Accelerated Heterologous 2-Dose Ebola Vaccine Regimens in Adults With and Without Human Immunodeficiency Virus in Africa

在非洲有和没有人类免疫缺陷病毒的成年人中加速异源2剂量埃博拉疫苗方案的安全性和免疫原性

2024-04-241
PRE
Differences in risk factors between a high and low vertical HIV transmission setting: implications for elimination of new paediatric HIV infections
2023-12-170
OA